AMBER GRANTHAM: Open Payments
NPI 1235689217 · BAXLEY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 29 payments from 13 companies in 2025. Trend: 2023 $217 · 2024 $551 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $97 |
| Sumitomo Pharma America, Inc. | 3 | $84 |
| ABBVIE INC. | 3 | $72 |
| Antares Pharma, Inc. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: GEMTESA, XYOSTED, VRAYLAR, CAPLYTA, Ozempic, Wegovy, AIRSUPRA, LINZESS.
Industry payments across GA — which companies pay providers there.
